Clinical Trials Logo

Clinical Trial Summary

Heart failure with preserved ejection fraction (HFpEF) was considered as a heterogeneous disease with multi-organ and multi-system design, which is related to various complications, such as hypertension, obesity and arteriosclerosis. Ambulatory arterial stiffness index (AASI) is associated with arteriosclerosis and hypertension. There is no report on whether AASI is associated with left ventricular diastolic dysfunction in patients with HFpEF.


Clinical Trial Description

Heart failure with preserved ejection fraction (HFpEF) is related to various complications, such as hypertension, obesity and arteriosclerosis. Ambulatory arterial stiffness index (AASI) is associated with arteriosclerosis and hypertension. AASI is especially associated with left ventricular diastolic dysfunction in patients with hypertension. Patients with HFpEF have obvious left ventricular diastolic insufficiency. However, there is still no research investigating the the relationship between AASI and left ventricular diastolic dysfunction in patients with HFpEF. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05059769
Study type Observational [Patient Registry]
Source Chongqing Medical University
Contact Zhang Dongying
Phone +8613608398395
Email [email protected]
Status Recruiting
Phase
Start date October 10, 2020
Completion date April 30, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05030987 - Renal Denervation to Treat Heart Failure With Preserved Ejection Fraction N/A
Recruiting NCT04153136 - Effects of Sacubitril/Valsartan on Subclinical Heart Failure in HIV (The ENCHANTMENT HIV Study) Phase 2
Recruiting NCT04535726 - The Relationship Between Blood Pressure and Arterial Stiffness in HFpEF Patients With Different Levels of Obesity
Recruiting NCT04594499 - The Relationship Between Pericardial Fat Thickness and Arterial Stiffness in HFpEF Patients
Recruiting NCT03550235 - Exploration of Dyspnea at Non-high Brain Natriuretic Peptide (BNP)
Recruiting NCT04633460 - Acute Effects of Exogenous Ketone Ester Administration in Heart Failure Phase 2
Not yet recruiting NCT05002075 - Efficacy of an m-Health Cardiac Rehabilitation Program in Heart Failure With Preserved Ejection Fraction N/A
Completed NCT01726049 - Sildenafil in HFpEF and PH Phase 3
Completed NCT01185067 - Physiological Effects of Grape Seed Extract in Diastolic Heart Failure Phase 1
Completed NCT01091467 - Prospective Study of Heart Failure With Preserved Left Ventricular Ejection Fraction
Completed NCT05068934 - The Relationship Between Epicardial Fat Tissue and Cardiac Function in HFpEF Patients
Recruiting NCT04913805 - Matching Perfusion and Metabolic Activity in HFpEF Phase 2
Not yet recruiting NCT04945707 - Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF) Phase 4
Not yet recruiting NCT05053256 - The Relationship Between Heart Function and Metabolism in HFpEF Patients
Recruiting NCT04237701 - Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System
Recruiting NCT05055180 - Right Ventricular Function and Pulmonary Hypertension in HFpEF
Enrolling by invitation NCT04019613 - Assessment of Pulmonary Congestion During Cardiac Hemodynamic Stress Testing N/A
Completed NCT03254485 - A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) Phase 2
Recruiting NCT02901184 - Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction Phase 3
Not yet recruiting NCT05057806 - SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan Early Phase 1